
|Articles|April 1, 2003
Technology in trials: Early results promising for presbyopia reversal
Orlando-Early results from a clinical trial for the reversal and treatment of presbyopia, using SurgiLight Inc.'s OptiVision technology, appear "promising," according to researchers at New York-Presbyterian Hospital Weill Cornell Medical Center.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
2
FDA guidance to help accelerate cell and gene therapies
3
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5





















